- Marketwired•2 months ago
Genetic Technologies Limited , a molecular diagnostics company and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for sporadic breast cancer, today announced that ...
- Marketwired•2 months agoGenetic Technologies Limited and The University of Melbourne Enter into Exclusive Worldwide License Agreement to Develop Colorectal Cancer Risk Assessment Test
Genetic Technologies Limited , a molecular diagnostics company and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for sporadic breast cancer, today announced the ...
- Marketwired•4 months agoGenetic Technologies Launches BREVAGenplus(R) Marketing Program Around Susan G. Komen(R)'s Race for the Cure(R) Events
Molecular diagnostics company Genetic Technologies Limited announced today that it will be conducting a promotional campaign around the Susan G. Komen Race for the Cure events. This program will commence ...
GENE : Summary for Genetic Technologies Ltd - Yahoo Finance
Genetic Technologies Limited (GENE)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.07 x 6000|
|Ask||1.19 x 1100|
|Day's Range||1.07 - 1.13|
|52 Week Range||1.04 - 2.89|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.80|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|